Science is the heart of the Sun. With that belief in mind, a company emerged in the year 1983 which has now become the fourth largest specialty generic pharmaceutical company in the world. Sun Pharma is a leading pharmaceutical company that provides high-quality, and affordable medicines to more than 100 countries worldwide. The company manufactures and markets many pharmaceutical formulations covering a broad spectrum of acute and chronic therapies, which includes generics, specialty, over-the-counter (OTC), antiretrovirals (ARVs), complex or difficult to make technology-intensive products, branded generics, Active Pharmaceutical Ingredients (APIs) and Intermediates. Covering neuro-psychiatry, cardiology, gastroenterology, anti-infectives, diabetology, oncology, ophthalmology, dermatology, urology, and nephrology, it sells over 30 billion doses every year. Sun Pharma has its presence in over 80 markets, out of which prominent emerging markets include Romania, Mexico, South Africa, Russia, and Brazil.
Dilip Shanghvi is the Founder and Managing Director of the company. He has extensive industrial experience in the pharmaceutical industry and has received many prestigious awards and recognitions for his valuable contribution to the pharmaceutical sector.
The product portfolio of the company is very comprehensive, diverse, and highly complementary. Its products range includes:
Over the years, Sun Pharma has built a strong portfolio of patent-protected specialty medicines. The key segments targetted by the company include dermatology, ophthalmology, and oncology. Its initiatives in this segment cover the entire value chain, right from in-licensing early-to-late stage clinical candidates, to getting access to on-market patented products.
To build the trust of both patients and healthcare professionals, all the products have the hallmark of technology-based differentiation and cover the full range of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids. The therapeutic segments covered in this portfolio of over 2000 molecules include psychiatry, anti-infectives, neurology, cardiology, orthopedic, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental, and Nutritionals.
This range includes some of its well-known and famous medications like Faringosept (sore throat), Revital (vitamins), and Volini (topical analgesics). There are other category-defining brands too like Coldact & Flustat (cold & flu), Brustan, Painamol & Paduden (analgesics), Aspenter, Aspacardin, Nudrate & Fortifikat (lifestyle OTCs), Gestid (digestives), and Chericof (cough).
Active Pharmaceutical Ingredients
As the company believes that APIs are a vital input in the manufacturing of complex formulations to facilitate vertical integration, it started producing APIs in 1995. Currently, the company manufactures APIs in 14 different manufacturing facilities located in India, Hungary, Israel, the US, and Australia. Its product list includes generics and complex APIs like anti-cancers, peptides, steroids, sex hormones, and controlled substances, including poppy-derived opiate raw materials and, are produced in isolated manufacturing areas.
Anti Retro Viral Medications
Intending to improve access and affordability, it offers a broad range of WHO prequalified ARV medicines. It also contributes to combating HIV/AIDS through its several first-line and second-line Highly Active Antiretroviral Therapy (HAART) regimens.
CORPORATE SOCIAL RESPONSIBILITY
The company believes that business and responsibility go hand in hand. Therefore, it conducts various CSR activities. Priority areas include health, education, drinking water, and sanitation.
- Malaria Elimination: Its Malaria Elimination Demonstration Project aims to eliminate Malaria from 1233 villages of the Mandla district.
- Mobile Healthcare Units: This initiative aims at delivering primary healthcare services to over 6,50,000 people located around areas close to the company’s manufacturing plants and other establishments.
- Sun Pharma Science Foundation: It encourages and rewards excellence in the medical and pharmaceutical sciences. It is an independent non-profit organization that promotes scientific endeavors in India.
CORE VALUES AND VISION
The company’s vision is to reach people and touch lives globally as a leading provider of valued medicines. It follows certain core values that represent its promise to all the stakeholders. These are maintaining quality, consistency, and reliability, building trust, and discovering and implementing new ideas. It endeavors to bring new and valuable products to the market and consistently deliver value to all the stakeholders.
AWARDS AND MILESTONES
Sun Pharma has been awarded many prestigious awards. Some of them are:
- The Golden Peacock Award for Corporate Social Responsibility, 2020
- The DIANA (Distribution Industry Award for Notable Achievements in Healthcare) award for ‘Best New Product Introduction/Promotion’ at the Annual Healthcare Distribution Alliance Conference 2021
- India Pharma Research Development Award 2015 from the Ministry of Chemicals & Fertilizers, Government of India
- NDTV Profit’s Business Leadership of the Year Pharmaceutical Award in 2012
All the scientists working in the company deliver high-quality products. Currently, the company has 2000 highly trained scientists who work in six research centers across India, Israel, and the US. Pioneering in delivery systems of ophthalmology, cardiology, peptides, CNS, and oncology, Sun Pharma is one of the valuable pharmaceutical companies in India.
1 thought on “SUN PHARMA: EXCELLING IN DEVELOPING GENERICS AND TECHNOLOGY COMPLEX PRODUCTS”